L Newman. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Agents/therapeutic useAntineoplastic Agents/toxicityAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/toxicityCisplatin/administration & dosageCisplatin/toxicityClinical Trials as TopicDoxorubicin/administration & dosageDoxorubicin/toxicityHumansMethotrexate/administration & dosageMethotrexate/toxicityRemission InductionTime FactorsTreatment OutcomeUrinary Bladder Neoplasms/drug therapyUrinary Bladder Neoplasms/mortalityVinblastine/administration & dosageVinblastine/toxicity
Substances： See more » Antineoplastic AgentsVinblastineDoxorubicinCisplatinMethotrexate
Year: 2001 PMID： 11438559 DOI： 10.1093/jnci/93.13.973
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506